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Aims The mechanisms involved in hypoxic pulmonary vasoconstriction (HPV) are not yet fully deﬁned.
The aim of the study was to determine the role of protein kinase C z (PKCz) and neutral sphingomyeli-
nase (nSMase) in HPV.
Methods and results Ceramide content was measured by immunocytochemistry and voltage-gated pot-
assium channel (KV) currents were recorded by the patch clamp technique in isolated rat pulmonary
artery smooth muscle cells (PASMC). Contractile responses were analysed in rat pulmonary arteries
mounted in a wire myograph. Pulmonary pressure was recorded in anesthetized open-chest rats.
Protein and mRNA expression were measured by western blot and RT–PCR, respectively. We found
that hypoxia increased ceramide content in PASMC which was abrogated by inhibition of nSMase, but
not acid sphingomyelinase (aSMase). The hypoxia-induced vasoconstrictor response in isolated pulmon-
ary arteries and the inhibition of KV currents were strongly reduced by inhibition of PKCz or nSMase but
not aSMase. The nSMase inhibitor GW4869 prevented HPV in vivo. The vasoconstrictor response to
hypoxia was mimicked by exogenous addition of bacterial Smase and ceramide. nSMase2 mRNA
expression was 10-fold higher in pulmonary compared with mesenteric arteries. In mesenteric
arteries, hypoxia failed to increase ceramide but exogenous SMase induced a contractile response.
Conclusion nSMase-derived ceramide production and the activation of PKCz are early and necessary
events in the signalling cascade of acute HPV.
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1. Introduction
Hypoxic pulmonary vasoconstriction (HPV) is an adaptive
physiological mechanism that optimizes blood oxygen satur-
ation by increasing pulmonary vascular resistance in poorly
aerated lung regions, thereby diverting pulmonary blood
ﬂow to the better ventilated ones.
1–7 HPV reﬂects an intrin-
sic property of the small pulmonary artery (PA) smooth
muscle cells (PASMC) in response to alveolar hypoxia. Gener-
alized alveolar hypoxia associated with altitude, atelectasis,
chronic obstructive pulmonary disease, or sleep apnea
induces HPV which, if sustained, may lead to pulmonary
hypertension and right ventricular failure. On the contrary,
failure of HPV, as occurs in adult respiratory distress syn-
drome, pneumonia, sepsis, or liver cirrhosis is often a criti-
cal determinant of ventilation–perfusion mismatch and,
hence, hypoxaemia.
8
Despite intensive research, the molecular basis of HPV
remains one of the most enduring mysteries of cell physi-
ology and several, sometimes contradictory, hypotheses
have emerged to explain it.
1–7,9–12 Nevertheless, there is
consensus about the involvement of a putative redox-based
O2 sensor, i.e. mitochondrial electron transport chain
2,4,5
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5,7 regulating the
activity of effector proteins and there is a large body of evi-
dence indicating a role of the reactive oxygen species (ROS)
as signalling intermediates. Voltage-gated K
þ (KV) channels
are known effector proteins which are inhibited by
hypoxia, leading to cell membrane depolarization and
opening of voltage-dependent L-type Ca
2þ channels.
1,7,9
Additional effectors include twin pore domain K
þ channels
whose inhibition also depolarizes the membrane,
store-operated Ca
2þ channels (SOCs) leading to increased
capacitative Ca
2þ entry and Rho kinase which is involved
in Ca
2þ-sensitization.
10–12
We have reported that protein kinase C z (PKCz)i s
involved in the KV channel inhibition and the pulmonary
vasoconstriction induced by the thromboxane A2 mimetic
U46619.
13 The role of this kinase, as well as its adaptor
protein p62, was recently conﬁrmed using PKCz
2/2 and
p62
2/2 mice.
14 PKCz is directly activated by ceramide,
15 a
sphingolipid-derived second messenger molecule. Ceramide
is synthesized from membrane sphingomyelin by sphingo-
myelin phosphodiesterases (SMPD: SMPD1, SMPD2, SMPD3,
and SMPD4), also known as acid or neutral sphingomyeli-
nases (aSMase, nSMase1, nSMase2, and nSMase3, respect-
ively) which are activated by multiple membrane
receptors and non-receptor stimuli.
16 SMases-derived cera-
mide production is an attractive candidate mechanism in
HPV because aSMase and nSMase are activated by ROS
16
and SMase and ceramide have been shown to inhibit KV
channels.
17,18
Herein, we show for the ﬁrst time that the activation of
nSMase and PKCz are necessary events in the signalling
of HPV.
2. Methods
The investigation conforms with the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of Health
(NIH Publication No. 85–23, revised 1996) and approved by our insti-
tutional review board. A detailed description of the experimental
methods is available in previous studies.
13,14,19,20 Third generation
PA (250–450 mm) and mesenteric arteries of similar diameter were
isolated from male Wistar rats and smooth muscle cells were
enzymatically isolated.
2.1 Solutions and hypoxia
Hepes-buffered solution contained (in mmol/L): NaCl 130, KCl 5,
MgCl2 1.2, CaCl2 1.5, glucose 10, HEPES 10, pH 7.3, and Krebs sol-
ution (in mmol/L): NaCl 118, KCl 4,75, NaHCO3 25, MgSO4 1,2,
CaCl2 2,0, KH2PO4 1,2, and glucose 11 bubbled with 21% O2,
5%CO2. For the in vitro experiments, hypoxia was induced by bub-
bling the Hepes solution with 100% N2 or the Krebs solution
with 95%N2–5% CO2 to achieve an oxygen concentration of 3–4%
(24+1 Torr) in the chamber. For the in vivo experiments, hypoxia
was induced by switching the inspiratory input from room air
(21% O2, normoxia) to a 10% O2–90% N2 gas.
2.2 Ceramide content
Freshly isolated cells adhered to gelatine-coated coverslips were
perfused with Hepes solution for 15 min with or without inhibitors
and subsequently with hypoxic solution during 0, 1, 3, or 5 min
and rapidly ﬁxed with 4% paraformaldehyde. Cells were stained
using an anti-ceramide antibody (15B4) and then with donkey anti-
rabbit FITC conjugated antibodies. Immunoﬂuorescence was quanti-
ﬁed using ImageJ (ver. 1.32j, NIH).
2.3 Contractile responses
PA rings were mounted in a wire myograph in Krebs solution and
stretched to give an equivalent transmural pressure of 30 mmHg.
21
Each vessel was exposed to three hypoxic challenges of 10 min dur-
ation each, leaving a 45 min incubation period in normoxia between
hypoxic challenges. The third hypoxic response was examined after
45 min incubation with vehicle (control) or different inhibitors and
the contractile responses were expressed as a percentage of the
second exposure to hypoxia.
2.4 Pulmonary arterial pressure
Pressure was recorded with a pressure transducer in anesthetized
(100 mg kg
21 ketamine plus 5 mg kg
21 diazepam) open chest rats
via a catheter advanced through the right ventricle and placed
into the main PA.
2.5 Electrophysiological studies
Membrane currentswererecordedusing thewhole-cell conﬁguration
ofthepatchclamptechnique.Cellsweresuperfusedwithanexternal
Ca
2þ-free Hepes solution and a Ca
2þ-free pipette (internal) solution
containing (mmol/L): KCl 110, MgCl2 1.2, Na2ATP 5, HEPES 10, EGTA
10, pH adjusted to 7.3 with KOH. Currents were evoked following the
applicationof200 msdepolarizingpulsesfrom 260 mVtotestpoten-
tials from 260 mV to þ60 mV in 10 mV increments.
2.6 Protein expression
Protein expression was quantiﬁed by western blotting using
anti-Kv1.5 (Alomone, Israel), anti-PKCz (Santa Cruz Biotechnology),
anti-a-actin (Sigma) antibodies, or an afﬁnity puriﬁed rabbit anti-
nSMase2 antibody (prepared by Genscript). The synthetic oligopep-
tide used for immunization was CRRRHPDEAFDHEVS (identical to the
335–348 amino acids of rat nSMase2 plus an N-terminal cystein and
similar to that used by Tani and Hannun
22).
2.7 Real-time RT–PCR
Total RNA was isolated and puriﬁed from arterial homogenates using
RNeasy Mini kit (Qiagen). Real-time PCR was performed using a
Taqman system (Roche Diagnostics, Mannheim, Germany) in the
Unidad de Genomica (Universidad Complutense de Madrid). Speciﬁc
primers were designed for rat aSMase (right 50- TTTCCCGAGCCCTGT
AGA-30 and left 50-ATCTGACCCACGCCAATG-30), nSMase1 (right
50-CCCCGTCCACTCTTTCAGTA-30 and left 50- GTGCGGGGATCTCAAC
AT-3), nSMase2 (right 50- TGAAAACATTATTGAGCCTTGC-30 and left
50-CTTTGCCACAGCCAATGTC-30), and b-actin (right 50-TCAGGCAGC
TCATAGCTCTTC-30 and left 50- GCCCTAGACTTCGAGCAAGA-30).
2.8 Statistical analysis
Data are expressed as means+SEM; n indicates the number of
animals, arteries, or cells tested. For multiple comparisons (e.g.
the effects of various inhibitors against a control), statistical analy-
sis was performed using a one-way ANOVA followed by a Bonferroni
post hoc test, otherwise (e.g. control vs. single treatment) using a
two-tailed Student’s t-test for paired or unpaired observations.
Differences were considered statistically signiﬁcant when P , 0.05.
3. Results
3.1 Effects of hypoxia on ceramide production in
isolated pulmonary artery smooth muscle cells
Exposure to hypoxia induced an increase in ceramide
content in freshly isolated PASMC (Figure 1A) which was sig-
niﬁcant after 1 min of perfusion with the hypoxic solution
and remained elevated for at least 5 min. We analysed the
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23 a speciﬁc inhibitor of
nSMase, and desipramine, speciﬁc for aSMase. GW4869,
but not desipramine (Figure 1B), inhibited hypoxia-induced
ceramide production, suggesting that hypoxia-induced cera-
mide production is derived from nSMase.
3.2 Role of protein kinase C z and nSMase in
hypoxia-induced contraction in isolated
pulmonary artery
Hypoxia induced a contractile response in isolated small pul-
monary arteries. In the absence of other vasoconstrictor
agent, this response was small in magnitude but rapid, sus-
tained, and reproducible (Figure 2A) and could also be
observed in endothelium-denuded arteries (not shown). The
magnitude of this response (0.08+0.01 mN, n ¼ 10) is
approximately 20% of the maximal response induced by the
thromboxane A2 mimetic U46619. This hypoxic contraction
was strongly inhibited by the PKCz pseudosubstrate inhibitory
peptide(PKCz-PI)(Figure2B)suggestingaroleforthiskinasein
HPV. GW4869 and the chemically unrelated nSMase inhibitor
manumycin A also inhibited the hypoxic-induced contraction
(Figure 1B). The effects of desipramine as aSMase inhibitor
werenotanalysedbecauseitisaknownCa
2þchannelantagon-
ist and inhibits agonist- and depolarization-induced contrac-
tions in vascular smooth muscle.
24 However, D609,
25 another
inhibitor of aSMase, had no effect on hypoxic contraction
(Figure 2B).
3.3 Role of nSMase in hypoxic pulmonary
vasoconstriction in vivo
To analyse the role of nSMase in HPV in vivo, we recorded PA
pressureviaacatheterlocatedinthePAthroughtherightven-
tricleinopen-chestventilatedrats.Asexpected,hypoxia(10%
O2) led to a reversible decrease in systemic pressure and an
increase in PA pressure, i.e. HPV (Figure 3A). Interestingly,
in rats treated with GW4869, hypoxia not only failed to
increase PA pressure but it even reduced it (Figure 3B). On
average, hypoxia increased by 7.3+1.3 mmHg (n ¼ 9) and
decreased by 5.3+1.1 mmHg (n ¼ 11) mean PA pressure in
vehicle and GW4869-treated rats, respectively (P , 0.05
vehicle vs. GW4869, unpaired Student’s t-test). The
hypoxic-induced pulmonary decrease in PA pressure in
GW4869-treated rats was reversible and reproducible (not
shown). In other set of experiments in closed chest rats,
GW4869 did not modify the hypoxia-induced decrease in sys-
temic pressure (n ¼ 5, Figure 3B).
3.4 Effects of exogenous SMase
As expected, exogenous addition of SMase from Bacillus
cereus, a homologue of mammalian nSMase, produced a
marked increase in ceramide content in isolated PASMC
(Figure 4A). Moreover, SMase mimicked the effects of
hypoxia, i.e. it produced a sustained contractile response
(Figure 4B) of a similar magnitude (0.10+0.04 mN, n ¼ 5)
to the response induced by hypoxia. However, the time
course of this contraction was slower than that induced by
hypoxia. This response was also present in endothelium-
denuded arteries (not shown). Exogenous addition of C6-
-ceramide also induced a contractile response (0.05+
0.01 mN, n ¼ 32, Figure 4C). This response was inhibited
by the PKCz-PI but not by the nSMase inhibitor GW4869.
The inhibitory effect of the Rho kinase inhibitor Y27632
and the L-type calcium channel blocker nifedipine on
ceramide-induced contraction did not reach statistical sig-
niﬁcance, but the effects of both drugs combined were
highly signiﬁcant (Figure 4D).
3.5 Hypoxic KV channel inhibition
As expected,
1,2 we found that hypoxia inhibited KV currents
(Figure 5) with a similar time course to the hypoxia-induced
ceramide production and contraction. These effects, as
shown above for hypoxia-induced vasoconstriction, were
Figure 2 Inhibition of protein kinase C z (PKCz) and nSMase but not aSMase
prevents hypoxia-induced vasoconstriction in pulmonary artery (PA) in vitro.
(A) Time course of the contractile response in PA mounted in a wire myograph
exposed to hypoxia at time 0 (representative tracing). (B) Effects of
PKCz-pseudosubstrate inhibitory peptide (10 mmol/L), the nSMase inhibitors
GW4869 (10 mmol/L, GW), and manumycin A (5 mmol/L, Manum) or the
aSMase inhibitor D609 (100 mmol/L) on the hypoxia-induced PA contraction.
Results are means+SEM. **indicates P , 0.01 vs. control (ANOVA followed
by a Bonferroni’s test).
Figure 1 Hypoxia induces ceramide production by the activation of nSMase.
(A) Top panel: time course of the decay in O2 as measured by a Clark elec-
trode in the chamber. Medium panel: cellular ceramide content determined
by immunostaining of PASMC with a monoclonal ceramide-speciﬁc antibody
15B4. Bottom panel: representative pictures of immunostained cells after
0, 1, 3, and 5 min of hypoxia. (B) Effects of 10 mmol/L GW4869 (GW) and
10 mmol/L desipramine, inhibitors of nSMase and aSMase, respectively, on
ceramide production stimulated by 3 min hypoxia. Results are means+SEM
(averaged FITC-ﬂuorescence intensity relative to cell surface measured in
three to four coverslips with at least 10 cells each), # indicates P , 0.05 nor-
moxia vs. hypoxia (unpaired t-test), **indicates P , 0.01 vs. control (ANOVA
followed by a Bonferroni’s test).
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and manumycin A.
3.6 Pulmonary selectivity
The mRNAs of aSMase and nSMase1 were similarly expressed
in PA and mesenteric arteries as measured by real-time
RT–PCR (Figure 6A). However, the mRNA expression of
nSMase2 was much higher in PA when compared with mesen-
teric arteries. The protein expression of nSMase2, PKCz, and
Kv1.5 was also higher in PA as measured by western blot
(Figure 6B). In addition, hypoxia failed to generate cera-
mide (Figure 6C) in mesenteric arteries. However, exogen-
ous SMase induced a contractile response in isolated
Figure 3 The nSMase inhibitor GW4869 reverses hypoxic pulmonary vasoconstriction in vivo. Recordings of systemic (left panel, in closed chest rats via a cath-
eter in the carotid artery) and pulmonary (right panel, in open chest rats via a catheter advanced through the right ventricle into the main pulmonary artery)
arterial pressure in anesthetized ventilated rats treated with DMSO (vehicle) (A) or 1 mg Kg
21 of GW4869 (B) administered intraperitoneally. Rats were exposed
to alveolar hypoxia (10% O2) as indicated.
Figure 4 Exogenous addition of bacterial SMase reproduces the effects of hypoxia on ceramide content and induces a contractile response in isolated pulmonary
artery (PA). (A) Effects of SMase (100 mU mL
21 from Bacillus cereus) on cellular ceramide content determined by immunostaining of pulmonary artery smooth
muscle cells with a monoclonal ceramide-speciﬁc antibody 15B4. Cells were exposed to SMase for 15 min. (B and C) Time course of the contractile response in PA
mounted in a wire myograph exposed to SMase (B) and C6-ceramide (C) at time 0 (representative tracings). (C) Effects of the nSMase inhibitor GW4869 (10 mmol/
L, GW), protein kinase C z-pseudosubstrate inhibitory peptide (10 mmol/L), the L-type Ca
2þ channel inhibitor nifedipine (1 mmol/L, Nifed), the Rho kinase inhibi-
tor Y27632 (10 mmol/L), or the combination of Nifed þY27632 on the contraction induced by C6-ceramide (10 mmol/L) in PA. Results are means+SEM of 6–10
experiments (except controls where n ¼ 32). * and ** indicates P , 0.05 and 0. 0.01, respectively, vs. control (ANOVA followed by a Bonferroni’s test).
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(Figure 6D).
4. Discussion
Herein we show that the activation of nSMase is required for
acute HPV (Figure 7). The speciﬁc inhibitors of nSMase but
not of aSMase strongly inhibited the constrictor response
to hypoxia in small PA. The time course of ceramide gener-
ation induced by hypoxia in isolated PASMC and the mimick-
ing effect of exogenous addition of SMase or ceramide are
consistent with this view. These events were observed in
non-genetically modiﬁed systems in vitro (rat PA or freshly
isolated PASMC) and the role of nSMase was also conﬁrmed
in vivo by using the speciﬁc inhibitor GW4869. The
hypoxia-induced increase in ceramide was not observed in
mesenteric arteries. In addition, the expression of nSMase2
as well as other signalling proteins PKCz and KV1.5 was
higher in small PA vs. mesenteric arteries.
HPV in vivo is a rapid and sustained response. Because
HPV responses are more readily and consistently observed
when the small PAs are pre-constricted, the addition of a
pre-constrictor agent has been a common practice in many
studies analysing HPV in vitro. In pre-constricted rat PA,
hypoxiaproducesatri-phasicresponse,withaninitialvasocon-
striction followed by vasodilation and a late slow-developing
contraction. However, under the right conditions of stretch, a
sustained constrictor response to hypoxia has been reported
with no added constrictor agent.
21 In order to avoid a possible
inﬂuence of a pre-constriction agent on the intracellular
signallingmediatingHPV,inthepresentstudyhypoxiccontrac-
tions were carried out in the absence of an agonist.
Several broad inhibitors of PKC isoforms have demon-
strated to be effective in inhibiting HPV in isolated perfused
lungs.
26 PKCz is activated by hypoxia in alveolar epithelial
cells
27 and is a known modulator of KV currents in PA.
13,14
Our data showing that PKCz-PI prevented the vasoconstric-
tion induced by hypoxia strongly suggest that PKCz is
involved in the signalling pathway of HPV.
PKCz is directly activated by ceramide.
15 Herein, we show
that hypoxia induced a rapid increase in ceramide content.
The role of nSMase as a source of ceramide was conﬁrmed
using the speciﬁc inhibitor GW4869,
23 whereas inhibition of
aSMase with desipramine was without effect. GW4869 and
the chemically unrelated nSMase inhibitor manumycin (but
not the aSMase inhibitor D609) inhibited the vasoconstrictor
Figure 5 Hypoxia-induced inhibition of KV currents in pulmonary artery
smooth muscle cells (PASMC) is prevented by inhibition of protein kinase C
z (PKCz) and nSMase. (A) Time course of hypoxia-induced KV current inhibition
as measured in the whole-cell conﬁguration of the patch-clamp technique in
PASMC (average percent change at þ30 mV depolarizing pulses and represen-
tative current traces for 200 ms depolarization pulses from 260 to þ60 mV in
10 mV increments from a holding potential of 260 mV before and after 5 min
of hypoxia), (B–D) Current–voltage relationship calculated from experiments
as in (A) performed in the absence (B) or in the presence of
PKCz-pseudosubstrate inhibitory peptide (0.1 mmol/L in the internal solution)
(C) or manumycin (5 mmol/L) (D). Results are means+SEM. *indicates P ,
0.05 vs. control (paired t-test).
Figure 6 Pulmonary selectivity. (A) Expression of aSMase, nSMase1, and
nSMase2 analysed by RT–PCR. Results are normalized to b-actin and
expressed as a percent of mean values of PA. (B) Protein expression of
nSMase2, protein kinase C z (PKCz), and KV1.5 analysed by western blot in
pulmonary artery (PA) and mesenteric arteries. Blots were re-probed with
smooth muscle a-actin as a loading control. Homogenates of Ltk
2 cells
expressing KV1.5 were also loaded in some gels as positive controls. Results
are normalized to a-actin and expressed as a percent of mean values of PA.
*indicates P , 0.05 vs. PA. (C) Ceramide production in mesenteric arteries,
under normoxia (n ¼ 14) and after 3 min hypoxia (n ¼ 19), determined by
immunostaining with a monoclonal ceramide-speciﬁc antibody (15B4). (D)
Time course of the contractile response in mesenteric arteries mounted in
a wire myograph exposed to SMase (100 mU mL
21 from Bacillus cereus)a t
time 0 (representative tracing). Results are means+SEM, n is shown in
parenthesis.
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vasoconstrictor response to hypoxia was mimicked by
exogenous addition of bacterial SMase or ceramide. The
effects of ceramide were prevented by PKCz-PI. However,
GW4869 did not modify ceramide-induced contractions
suggesting that the effects of GW4869 are related to the inhi-
bition of nSMase and not to a non-speciﬁc effect on smooth
muscle contraction. Interestingly, GW4869 completely abol-
ished the hypoxia-induced increase in PA pressure in vivo.
Moreover, after nSMase inhibition, hypoxia induced a revers-
ible and reproducible decrease in pulmonary arterial
pressure, i.e. a characteristic feature of systemic vascular
beds. Taken together, these results indicate that nSMase
plays a fundamental role in HPV.
KV channels are known targets of hypoxia in PA.
1,2 Hypoxia
inhibited KV currents in PASMC and this effect was prevented
by PKCz-PI and manumycin A, implying that hypoxic regu-
lation of KV channels is mediated via PKCz and nSMase.
However, our data do not exclude that other effector pro-
teins such as Rho kinase, twin pore domain K
þ,o r
voltage-independent Ca
2þ channels, possibly regulated via
nSMAse-derived ceramide, might also be involved in
HPV.
11,12,28 Accordingly, examples of Rho kinase or SOC
activation by ceramide have been reported in other cell
types.
29,30 Herein we also show that the contractile
responses induced by ceramide were inhibited by the Rho
kinase inhibitor Y27632 and the Ca
2þ channel blocker
nifedipine.
Because vasoconstriction induced by hypoxia is a unique
property of the small pulmonary vasculature,
1–7 the poten-
tial mechanisms involved in HPV should be also exclusive
to small PA. Thus, we analysed the expression of signalling
proteins and the functional differences between PA and
mesenteric arteries as prototype systemic arteries. The
failure of isolated smooth muscle cells from mesenteric
arteries to generate ceramide in response to hypoxia indi-
cates that hypoxic activation of nSMAse is speciﬁc of PA.
This speciﬁcity may be related in part to a higher expression
of nSMase2 in small PA. However, it seems also possible that
differences in the upstream mechanisms activating nSMase
(e.g. the oxygen sensor or the redox response to hypoxia)
may account for the pulmonary speciﬁcity. The expression
of other signalling proteins involved, i.e. PKCz and KV1.5
(a speciﬁc KV channel protein suggested to be involved in
HPV
31), was also higher in PA compared with mesenteric
arteries. However, exogenous addition of SMase also
induced a contractile response in mesenteric arteries
suggesting that pulmonary selectivity is related to differ-
ences in the activation of nSMase rather than in the response
to SMase.
Generalized alveolar hypoxia associated with altitude,
atelectasis, chronic obstructive pulmonary disease, or
sleep apnea leads to HPV and, hence, pulmonary hyperten-
sion.
8 The present study identiﬁes nSMase and PKCz as two
novel mediators of acute HPV. It is noteworthy that nSMase
does not appear to play a role in the control of systemic vas-
cular tone as opposed to its downstream effectors KV or
L-type Ca
2þ channels, suggesting that their inhibitors may
selectively inhibit HPV without inducing systemic hypoten-
sion, a common side effect of vasodilators used in pulmonary
hypertension. Interestingly, aSMase and PKCz have been also
proposed as therapeutic targets in acute lung injury
25 and
asthma,
32 respectively.
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